Record ID | ia:hydralazineincar0000unse |
Source | Internet Archive |
Download MARC XML | https://archive.org/download/hydralazineincar0000unse/hydralazineincar0000unse_marc.xml |
Download MARC binary | https://www.archive.org/download/hydralazineincar0000unse/hydralazineincar0000unse_meta.mrc |
LEADER: 03111cam 2200745Ia 4500
001 ocm06339723
003 OCoLC
005 20210820080807.0
008 800520s1979 enk b 100 0 eng d
010 $a 79050435
040 $aNOH$beng$cNOH$dOCL$dNLM$dOCLCQ$dMUQ$dNLE$dTPH$dOCLCF$dOCLCO$dOCLCQ$dOCLCO$dOCL$dOCLCQ$dBUB$dOCLCO$dUWO$dOCLCO$dOCLCA$dOCLCQ$dUKMGB
015 $aGB7922488$2bnb
016 7 $a8400402$2DNLM
016 7 $a012295306$2Uk
019 $a877039014
020 $a080891202X$q(Grune & Stratton)
020 $a9780808912026$q(Grune & Stratton)
020 $a0127907378
020 $a9780127907376
035 $a(OCoLC)6339723$z(OCoLC)877039014
050 4 $aRM666.H7$bH9
050 00 $aRC684.C
060 00 $aW3$bIN207 no.10 1979
082 04 $a615.71
082 00 $a616.1$b061$218
082 00 $a616.6/1/061$218
245 00 $aHydralazine in cardiovascular medicine /$cedited by D.M. Burley and C.A.S. Wink.
260 $aLondon :$bRoyal Society of Medicine ;$aNew York :$bGrune & Stratton,$c1979.
300 $aix, 47 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aInternational congress and symposium series - Royal Society of Medicine ;$vno. 10
504 $aIncludes bibliographical references.
540 $aCurrent Copyright Fee: GBP154.00$c0.$5Uk
650 0 $aHeart$xDiseases$xChemotherapy$vCongresses.
650 0 $aHydralazine$vCongresses.
650 0 $aKidneys$xDiseases$xChemotherapy$vCongresses.
650 1 $aKidneys$xDiseases$xChemotherapy$vCongresses.
650 1 $aHydralazine$vCongresses.
650 2 $aCardiovascular Diseases$xdrug therapy.
650 2 $aHydralazine$xpharmacology.
650 2 $aHydralazine$xtherapeutic use.
650 6 $aHydralazine$xCongrès.
650 6 $aAppareil cardiovasculaire$xMaladies$xChimiothérapie$xCongrès.
650 6 $aAgents cardiovasculaires$vCongrès.
650 7 $aHeart$xDiseases$xChemotherapy.$2fast$0(OCoLC)fst00953529
650 7 $aHydralazine.$2fast$0(OCoLC)fst00964562
650 7 $aKidneys$xDiseases$xChemotherapy.$2fast$0(OCoLC)fst00987391
653 $aMan$aHeart$aDrug therapy$aHydralazine
653 $aMan$aKidneys$aDrug therapy$aHydralazine
655 2 $aCongress.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
700 1 $aBurley, D. M.,$eeditor.
700 1 $aWink, C. A. S.,$eeditor.
710 2 $aRoyal Society of Medicine (Great Britain)
776 08 $iOnline version:$tHydralazine in cardiovascular medicine.$dLondon : Royal Society of Medicine ; New York : Grune & Stratton, 1979$w(OCoLC)570431075
776 08 $iOnline version:$tHydralazine in cardiovascular medicine.$dLondon : Royal Society of Medicine ; New York : Grune & Stratton, 1979$w(OCoLC)609298198
830 0 $aInternational congress and symposium series ;$vno. 10.
029 1 $aAU@$b000002558008
029 1 $aNLM$b8400402
029 1 $aZWZ$b022643907
029 1 $aUKMGB$b012295306
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 45 OTHER HOLDINGS